RF microneedling device expands cleared indications to include eye-area treatment across all skin types.
SkinStylus has received FDA clearance for the improvement of periorbital wrinkles across all skin types, adding a new indication to its radiofrequency microneedling platform. The clearance expands the device's addressable market into a high-demand anatomical zone where practices already perform filler and neuromodulator work.
The periorbital region has historically been challenging for RF microneedling due to proximity to the eye and variable skin thickness, making this clearance clinically and commercially significant. The all-skin-type language removes the need for separate protocols by Fitzpatrick classification, simplifying patient selection and treatment planning.
RF microneedling now cleared for periorbital wrinkles across all skin types.
For practices already running SkinStylus, this is a straightforward revenue add—the device footprint is already there, and periorbital work pairs naturally with existing toxin and filler revenue. The indication also positions the device against fractional CO2 and erbium lasers in the fine-line space, where downtime and post-inflammatory hyperpigmentation remain concerns.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
